Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
BioAlliance Pharma
BioAlliance Pharma
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Finance
Shareholders approve merger of BioAlliance Pharma and Topotarget
The combined business will be renamed Onxeo after completion of the transaction
Research & Development
Merger of BioAlliance Pharma and Topotarget to create new company called Onxeo
Transaction is expected to be completed in July/August
Finance
BioAlliance Pharma to merge with Topotarget
The companies have a pipeline of orphan oncology drugs
Manufacturing
BioAlliance Pharma collaborates with Penn Pharma on development of Validive
BioAlliance Pharma entrusts the pharmaceutical development of Validive to Penn Pharma, including the production of phase III clinical batches and the commercial production
Pharmaceutical
BioAlliance Pharma makes appointment
Judith Greciet put in charge of operations and r&d as deputy chief operating officer
Research & Development
BioAlliance receives €2m for Lauriad research project
French firm will capitalise on its mucosal expertise
Research & Development
BioAlliance receives ANR funding
To develop new applications of its mucoadheasive Lauriad technology
Subscribe now